State of the Art Review: Benefits and Harms of Intensive Glycemic Control in Patients with Type 2 Diabetes
6 Nov, 2019 | 08:37h | UTCBenefits and harms of intensive glycemic control in patients with type 2 diabetes – The BMJ (free for a limited period)
Related Commentary on Twitter
Evidence over the past decade has shown that the aggressive efforts often needed to achieve low HbA1c levels can lead to worse clinical outcomes. This review provides a summary of the evidence on the benefits and harms of intensive glycemic control https://t.co/rghp5iVRfX
— The BMJ (@bmj_latest) November 5, 2019